IDS Antibodies

Santa Cruz Biotechnology features a diverse variety of IDS Antibodies for studying the insulin-degrading enzyme (IDE). IDS Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The insulin-degrading enzyme plays a crucial role in regulating insulin levels and metabolizing amyloid-beta peptides, making it significant in diabetes and Alzheimer's disease research. By facilitating peptide breakdown, IDE helps maintain cellular homeostasis and prevents toxic protein accumulation. Understanding IDE function and regulation is essential for developing therapeutic strategies for metabolic and neurodegenerative disorders. Research into IDE mechanisms continues to reveal new insights about its role in maintaining cellular health. Investigating IDE activity patterns helps scientists better understand its influence on insulin processing and protein degradation pathways. IDS monoclonal antibodies from Santa Cruz Biotechnology enable researchers to advance scientific understanding of metabolic and neurodegenerative conditions through precise and reliable experimental methods.